CFTR corrector 4
CAS No. 1918142-34-3
CFTR corrector 4( —— )
Catalog No. M32840 CAS No. 1918142-34-3
CFTR corrector 4 is a potent and orally available transmembrane conductance regulator (CFTR) for cystic fibrosis and is a potent (R,R) type active enantiomer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 103 | Get Quote |
|
| 5MG | 169 | Get Quote |
|
| 10MG | 264 | Get Quote |
|
| 25MG | 518 | Get Quote |
|
| 50MG | 730 | Get Quote |
|
| 100MG | 1017 | Get Quote |
|
| 500MG | 2034 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCFTR corrector 4
-
NoteResearch use only, not for human use.
-
Brief DescriptionCFTR corrector 4 is a potent and orally available transmembrane conductance regulator (CFTR) for cystic fibrosis and is a potent (R,R) type active enantiomer.
-
DescriptionCFTR corrector 4 (Compound 13), an active (R,R)-form enantiomer, is a highly potent and orally active cystic fibrosis transmembrane conductance regulator (CFTR) corrector. CFTR corrector 4 can increase CFTR levels at the cell surface and have the potential for treatment of cystic fibrosis.
-
In VitroCFTR corrector 4 possesses high potency and efficacy with a EC50 of 0.028 μM in this HBE-TECC assay that assess the CFTR function, this lead resides in undesirable drug-like space with high molecular weight, and high HPLC Log?D, indicating high lipophilicity. HBE-TECC: (Human?Bronchial?Epithelial-Trans-Epithelial?Current?Clamp) assay.CFTR corrector 4 is tested its potency and efficacy in human bronchial epithelial (HBE) cells with a EC50 value 130 nM in the cell surface expression (CSE-HRP) assay.
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetCFTR
-
RecptorCFTR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1918142-34-3
-
Formula Weight539.52
-
Molecular FormulaC29H27F2NO7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 110 mg/mL (203.88 mM; Ultrasonic )
-
SMILESCOc1ccc2[C@@H](C[C@@H](Oc2c1)c1ccc(OC)c(OC)c1)NC(=O)C1(CC1)c1ccc2OC(F)(F)Oc2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang X, et al. Discovery of 4-[(2R,4R)-4-({[1-(2,2-Difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl}amino)-7-(difluoromethoxy)-3,4-dihydro-2H-chromen-2-yl]benzoic Acid (ABBV/GLPG-2222), a Potent Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)?
molnova catalog
related products
-
UCCF-853
UCCF-853 is a small-molecule CFTR modulator that can be used to study cystic fibrosis.
-
SRI-37240
SRI-37240 is a potent inhibitor of premature termination codons (PTCs) with read-across activity that induces a prolonged pause at the termination codon and inhibits PTCs associated with cystic fibrosis.
-
BPO-27 racemate
BPO-27 is a potent, metabolically stable CFTR inhibitor (IC50= 8 nM).
Cart
sales@molnova.com